Paul Deslandes

Dr. Paul Deslandes is affiliated with the Faculty of Life Sciences and Education at the University of South Wales, where he contributes to the Health, Care and Wellbeing Research and Innovation Group. He has served as a Lecturer and has been involved in research collaborations with institutions such as Cardiff Metropolitan University. His academic activities span from 2016 to 2024, with a strong focus on clinical pharmacology and primary care policy in Wales.

Dr. Deslandes' research interests lie at the intersection of clinical pharmacology, primary health care, mental health, and pharmaceutical policy. His work investigates antidepressant prescribing patterns, adverse drug reactions, non-medical prescribing, and the integration of pharmacists into mental health teams. He has contributed to evaluating national prescribing and reporting indicators in Wales, particularly related to dosulepin and SSRIs.

His recent publications (2016–2024) show a consistent focus on medication safety, prescribing practices, and healthcare policy evaluation in primary care settings. The research employs longitudinal data analysis, stakeholder surveys, and pharmacovigilance frameworks, often in collaboration with public health and clinical pharmacology experts.

Dr. Deslandes has not received any explicitly mentioned scientific awards in the provided text. He has participated in research activities such as the TAPERS project and RCBC First into Research fellowship, serving as a Consultant, Visiting Researcher, and Lecturer.

There is no information available about students he may have advised. His research is conducted within collaborative teams focused on improving medication use and patient outcomes in Wales, particularly through policy-driven interventions and interdisciplinary healthcare models.